:: Neglected diseases receive attention ::
       
     
Medicins Sans Frontieres has set up a 
not-for-profit drug research organisation called The 
Drugs for Neglected Diseases Initiative.
This initiative aims to develop drugs for diseases such as 
sleeping sickness, 
leishmaniasis + 
Chagas disease which together infect 
350 million poor people every year, but which are not financially attractive enough for the world's commercial drug companies to work on. 
Apparently, only 
10% of the world's health budget is spent on tackling tropical diseases - although they account for 
90% of the global disease burden.   
MSF therefore aims to challenge the 
world's public sector and charitable foundations to fund 
$250 million of work, over the next 
12 years, in order to ensure that latest expertise + technology are applied to tackling some of the diseases which cause the greatest suffering.